NCT03225534

Brief Summary

This proposal relates to the testing of several specific hypotheses in a subset of 500 participants in the Canadian Healthy Infant Longitudinal Development (CHILD) Study. These 500 now have complete data from the time of recruitment (in pregnancy) to age 1 year. The primary purpose of this proposal is to identify risk factors for early allergic outcomes and biomarkers that may predict future disease. These 500 infants will provide critical preliminary data, not only related to early outcomes, but also to inform analytical plans for the full CHILD cohort.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2008

Longer than P75 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 31, 2008

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2012

Completed
4.7 years until next milestone

First Submitted

Initial submission to the registry

July 7, 2017

Completed
14 days until next milestone

First Posted

Study publicly available on registry

July 21, 2017

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2018

Completed
Last Updated

September 25, 2017

Status Verified

September 1, 2017

Enrollment Period

4.2 years

First QC Date

July 7, 2017

Last Update Submit

September 21, 2017

Conditions

Keywords

AsthmaAllergyEpidemiologyEnvironmentExposures

Outcome Measures

Primary Outcomes (1)

  • Allergic sensitization at 1 year

    Skin prick tests to food and inhalant allergies

    March 2018

Secondary Outcomes (2)

  • Early childhood wheeze

    Birth to one year

  • Atopic Dermatitis

    Birth to one year

Other Outcomes (1)

  • Food Allergy

    Birth to one year

Eligibility Criteria

Age1 Day - 18 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

The 500 children in Project 500 will be representative of our full cohort. Study members have been recruited from a general population (i.e., not high-risk for asthma and allergy as are many cohorts) from recruitment bases in Vancouver, Edmonton, Winnipeg (including a rural site in Manitoba) and Toronto.

You may qualify if:

  • Pregnant women aged 18 years and older (19 in Vancouver) 2. Residence in reasonable proximity to the delivery hospital 3. Able to read, write, and speak English 4. Willing to provide informed consent 5. Willing to consent to cord blood collection for the study 6. Planning to give birth at a designated recruitment centre participating hospital 7. Infants born at or after 35 weeks 8. Able to provide address and telephone number and names and telephone numbers of two alternate contact individuals

You may not qualify if:

  • Children with major congenital abnormalities or respiratory distress syndrome (RDS)
  • Expectation of moving away from a recruitment area within year 1
  • Children of multiple births
  • Children resulting from in vitro fertilization
  • Children who will not spend at least 80% of nights in the index home

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (4)

  • Takaro TK, Scott JA, Allen RW, Anand SS, Becker AB, Befus AD, Brauer M, Duncan J, Lefebvre DL, Lou W, Mandhane PJ, McLean KE, Miller G, Sbihi H, Shu H, Subbarao P, Turvey SE, Wheeler AJ, Zeng L, Sears MR, Brook JR; CHILD study investigators. The Canadian Healthy Infant Longitudinal Development (CHILD) birth cohort study: assessment of environmental exposures. J Expo Sci Environ Epidemiol. 2015 Nov-Dec;25(6):580-92. doi: 10.1038/jes.2015.7. Epub 2015 Mar 25.

    PMID: 25805254BACKGROUND
  • Moraes TJ, Lefebvre DL, Chooniedass R, Becker AB, Brook JR, Denburg J, HayGlass KT, Hegele RG, Kollmann TR, Macri J, Mandhane PJ, Scott JA, Subbarao P, Takaro TK, Turvey SE, Duncan JD, Sears MR, Befus AD; CHILD Study Investigators. The Canadian healthy infant longitudinal development birth cohort study: biological samples and biobanking. Paediatr Perinat Epidemiol. 2015 Jan;29(1):84-92. doi: 10.1111/ppe.12161. Epub 2014 Nov 18.

    PMID: 25405552BACKGROUND
  • Subbarao P, Anand SS, Becker AB, Befus AD, Brauer M, Brook JR, Denburg JA, HayGlass KT, Kobor MS, Kollmann TR, Kozyrskyj AL, Lou WY, Mandhane PJ, Miller GE, Moraes TJ, Pare PD, Scott JA, Takaro TK, Turvey SE, Duncan JM, Lefebvre DL, Sears MR; CHILD Study investigators. The Canadian Healthy Infant Longitudinal Development (CHILD) Study: examining developmental origins of allergy and asthma. Thorax. 2015 Oct;70(10):998-1000. doi: 10.1136/thoraxjnl-2015-207246. Epub 2015 Jun 11.

    PMID: 26069286BACKGROUND
  • Azad MB, Robertson B, Atakora F, Becker AB, Subbarao P, Moraes TJ, Mandhane PJ, Turvey SE, Lefebvre DL, Sears MR, Bode L. Human Milk Oligosaccharide Concentrations Are Associated with Multiple Fixed and Modifiable Maternal Characteristics, Environmental Factors, and Feeding Practices. J Nutr. 2018 Nov 1;148(11):1733-1742. doi: 10.1093/jn/nxy175.

Related Links

Biospecimen

Retention: SAMPLES WITHOUT DNA

Cord blood. Child 1 year blood Child 5 year blood. Parental venous blood. Saliva samples. Urine samples. Stool samples. Breast milk samples. Nasal swabs.

MeSH Terms

Conditions

Genetic Predisposition to DiseaseAsthmaHypersensitivity

Condition Hierarchy (Ancestors)

Disease SusceptibilityDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateImmune System Diseases

Study Officials

  • Padmaja Subbarao, MD

    University of Toronto

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Medicine

Study Record Dates

First Submitted

July 7, 2017

First Posted

July 21, 2017

Study Start

August 31, 2008

Primary Completion

October 31, 2012

Study Completion

March 31, 2018

Last Updated

September 25, 2017

Record last verified: 2017-09

Data Sharing

IPD Sharing
Will not share